IBC’s 7th Annual Generics Asia Summit is the longest running conference to bring together the East and West together to discuss strategies in branded generics.

As innovators continue honing their defensive strategies in the West while focusing growth in the East, generic companies in Asia are now strategically positioned to provide local knowledge or compete for position in established but also increasingly emerging markets. In this 7th Annual Summit: Branded Generics Strategy Asia attention will shift towards how innovators, generics companies and investors will play in future markets. Be privy to the latest industry knowledge, open and in-depth dialogues and insights from regional and global leaders. In order to succeed in the ever competitive generics pie, networking and knowledge is key.

• 20+ speakers providing insights into opportunities and challenges in pharmerging Asia
• Newly REBRANDED Generics Asia Summit promises to deliver the same quality speakers and networking opportunities
• BRINGING together an unprecedented mix of Innovators + Generic perspectives
• ONLY conference in Asia to explore in depth the Branded Generics growth and resistance in the region
• LEARN how and if the Biosimilars opportunity is the right move for your business
• EXPAND your current capabilities through strategic collaborations to increase revenue
• PREPARE your future pipelines with knowledge gained from this all rounded conference
• MORE updates - Addressing pricing strategies across Asia
• Featuring how Big Pharma is managing post blockbuster patent expiries
• REVISED FORMATS with illuminating debate from dual Pharma and Generic perspectives – sustainable strategies in the generic race

Rafael Mendoza EP Director, Emerging Asia, Pfizer, China

Dr Robin Zhang Senior Strategic Marketing Manager, Bayer Healthcare, China

Deepak Sapra Senior Director, Business Development and Portfolio, Global Generics, Dr Reddy’s Laboratories, India

“ Eye Opening & relative to industry”
Chen, Eisai (M) Sdn Bhd

“ Networking and excellent presentations”
Runkel, Actavis

“This conference provides a good outlook for the generic industry, especially in the SEA context”
Heng, Novozymes

“There was great interaction between speakers & audience”
Cher, Business Monitor International